Graham Capital Management’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $219K | Buy |
+34,153
| New | +$219K | ﹤0.01% | 1058 |
|
|
2024
Q4 | – | Sell |
-67,956
| Closed | -$220K | – | 1187 |
|
|
2024
Q3 | $220K | Sell |
67,956
-253,911
| -79% | -$823K | ﹤0.01% | 853 |
|
|
2024
Q2 | $612K | Sell |
321,867
-202,760
| -39% | -$385K | 0.01% | 496 |
|
|
2024
Q1 | $1.49M | Buy |
+524,627
| New | +$1.49M | 0.03% | 286 |
|
|
2023
Q4 | – | Sell |
-56,241
| Closed | -$1.03M | – | 958 |
|
|
2023
Q3 | $1.03M | Buy |
56,241
+25,689
| +84% | +$470K | 0.02% | 345 |
|
|
2023
Q2 | $659K | Buy |
+30,552
| New | +$659K | 0.02% | 472 |
|